The value of adjuvant chemotherapy is controversial.
而辅助性化疗的价值存在争议。
Chemotherapy given in this manner is called adjuvant chemotherapy.
以这种方式进行的化疗被称为辅助化疗。
At least 6 months had to have passed since prior adjuvant chemotherapy.
至少离前期的辅助化疗有6个月。
To evaluate the effect of adjuvant chemotherapy in invasive bladder cancer.
评估辅助性化学治疗用于侵犯性膀胱癌之效果。
The main treatments were operations , adjuvant chemotherapy or radiotherapy.
治疗主要采用手术、化疗或放疗。
These results highlight the urgent need for further research into the use of adjuvant chemotherapy.
这些结果突显了对辅助性化学治疗更进一步研究的必要性。
PURPOSE Premenopausal women with breast cancer receiving adjuvant chemotherapy are at risk for amenorrhea.
目的：绝经前女性乳腺癌患者接受辅助化疗存在闭经风险。
Objective:To explore the types and causes of infection postoperative adjuvant chemotherapy in breast cancer.
目的：探讨乳腺癌术后化疗后感染类型及病因。
In this paper, the new WHO diagnosis standard and conservative surgery and adjuvant chemotherapy are described.
本文介绍了最新的WHO病理诊断标准以及保守手术和辅助化疗的进展。
Objective To study the clinical effects of new adjuvant chemotherapy on locally advanced carcinoma of the cervix.
目的观察新辅助化疗对局部晚期宫颈癌的临床疗效。
Objective:Making Retrospective a na lyses of the osteosarcoma patients adopting new adjuvant chemotherapy in36ca ses.
目的：对36例采用新辅助化疗的骨肉瘤患者进行回顾性分析。
In the absence of a clinical trial adjuvant chemotherapy and radiation therapy may be considered on an individual basis.
没有临床试验时，辅助的化疗和放疗对于个体病人是可以考虑的。
Adjuvant Chemotherapy for Stage III Colon Cancer: Do Physicians Agree About the Importance of Patient age and Comorbidity?
医生认为II I期结肠癌新辅助化疗的患者年龄和伴随疾病重要吗？
The European Study Group for Pancreatic Cancer is now conducting a meta-analysis of trials of adjuvant chemotherapy worldwide.
胰腺癌欧洲研究小组目前正在全世界进行辅助性化学疗法的共同分析。
"Our results provide support for the belief that adjuvant chemotherapy improves survival among older women," the authors write.
作者写到，我们的研究结果支持辅助化学治疗可以改善高龄女性预后的想法。
Methods:Retrospective analysis was applied to 7 cases of breast cancer with infection after postoperative adjuvant chemotherapy.
方法：对7例乳腺癌术后放化疗后出现感染的患者资料进行回顾性分析。
Objective: To study adverse drug reactions (ADRs) of adjuvant chemotherapy and hormonal treatment of patients with breast cancer.
目的：了解乳腺癌辅助化疗及激素治疗的药物不良反应。
Objective To analyse the effect of adjuvant chemotherapy combined radiotherapy of advanced nasopharyngeal carcinoma (N2, N3 stage).
目的分析评价晚期(N 2, N3期)鼻咽癌放疗加辅助化疗的疗效。
Conclusion the treatment style of curative resection combined with adjuvant chemotherapy is reasonable for right pulmonary PN2 cases.
结论以手术为主的综合治疗是右肺PN 2非小细胞肺癌较好的治疗模式。
The optimal sequencing of adjuvant chemotherapy (CT) and radiation therapy (RT) in patients with early-stage breast cancer remains unclear.
辅助放疗和化疗在早期乳腺癌的最佳顺序至今仍没有结论。
Method: 11 patients with the diagnosis of osteosarcomas of the extremities were treated with adjuvant chemotherapy and limb salvage surgery.
方法：对11例四肢骨肉瘤患者进行保肢治疗，其中11例进行了术前、后新辅助化疗。
Objecttive To evaluate the clinical effectiveness of limb salvage surgery combined with new adjuvant chemotherapy for extremity osteosarcoma.
目的评价保肢手术结合新辅助化疗治疗肢体骨肉瘤的临床疗效。
Purpose to evaluate whether diabetes affects patterns of adjuvant chemotherapy use, toxic effects of chemotherapy, and breast cancer outcomes.
目的：评估糖尿病是否影响化疗模式使用、化疗毒性反应和乳腺癌治疗效果。
Conclusion Neo-adjuvant chemotherapy with ET regimen for 4 cycles were more effective than 2 cycles to down staging locally advanced breast cancer.
结论ET方案对局部进展期乳腺癌进行新辅助化疗，在肿瘤及淋巴结缩小（降期）效果方面，4周期组明显优于2周期组。
CONCLUSION Physical and psychosocial functioning improved significantly after breast cancer treatment, independent of receipt of adjuvant chemotherapy.
结论：乳腺癌辅助化疗后生理和心理功能明显改善，不受辅助化疗方案的影响。
Conclusions: Our findings suggest that non-apoptotic fragments contribute to a higher degree to the change of the DNA level during adjuvant chemotherapy.
结论：我们的发现提示化疗患者血清dna增高主要是没有凋亡的长片段引起。
In the current case, we are dealing with a patient who has suffered a rapid (and symptomatic) relapse of her breast cancer following adjuvant chemotherapy.
就此病例而言，我们碰到了一个在助理化疗后很快复发而且有症状的患者。
We had 20 patients receiving adjuvant chemotherapy and 62 patients of local-advanced or with tumor recurrence or metastasis receiving palliative chemotherapy.
其中行术后辅助化疗20例，因局部晚期或复发、转移行姑息化疗62例。
Objective To investigate the effects of survival rate in the use of adjuvant chemotherapy containing paclitaxel on patients with breast cancer of HER-2 positive.
目的探讨含紫杉醇类辅助化疗方案对HER - 2(表皮生长因子受体2)阳性乳腺癌患者生存率的影响。
Adjuvant chemotherapy is a major part of comprehensive treatment for breast cancer, and it is also Paramount for preventing distal metastasis of the breast cancer.
辅助化疗是乳腺癌综合治疗中的重要组成部分，也是预防远处转移的主要手段。
应用推荐